CD8A and Epstein-Barr virus infection: In order to assess the role of EBV latent and lytic protein-specific CD8+ T cells in the control of EBV infection, we established numerous CD8+ T cell clones specific to representative immunodominant HLA-A*02 epitopes such as LMP2426–434 (latent) and BMLF1259–267 (lytic) from the blood of an HLA-A*0201 positive healthy EBV carrier (Figure 3A).